The grandaddy of gene-editing stocks recently provided an encouraging update, but it isn't the only experimental hemophilia therapy out there.Cory Renauer (TMFang4apples)Apr 3, 2019 at 8:13AM网页链接 $Sangamo Therapeutics(SGMO)$